Trends in M&A and Business Succession in the Drugstore Industry – 2025 Latest – Japan M&A Center

This news article discusses the importance and practical issues of business succession in the medical industry, while touching upon M&A and business succession trends in the drugstore industry.

The drugstore industry is also facing challenges such as an aging population and a lack of successors, leading to increased M&A activity for business expansion and securing management resources. This suggests that similar structural issues exist in the medical industry, making business succession an urgent management challenge.

In particular, business succession for medical institutions requires consideration from multiple perspectives, not just the transfer of assets and profits, but also the quality of medical care, impact on patients, and contribution to regional healthcare. The "schemes unique to medical corporations," "appropriate enterprise valuation," and "post-succession follow-up" mentioned in the news are precisely the core aspects of medical M&A and business succession. Within legal and institutional constraints such as equity transfer and changes in membership, a comprehensive valuation is required, encompassing not only medical profits but also intangible assets such as fixed assets, licenses, staff, and patient base.

For managers and potential successors, this news serves as a reminder of the importance of "early action." Business succession, including candidate selection, collaboration with M&A advisors, due diligence, and legal procedures, takes more time than anticipated. Furthermore, services such as "free consultations and preliminary assessments" can be valuable opportunities to utilize during the initial stages of information gathering and comparison. Not hesitating to consult with experts to objectively grasp the current situation of one's institution and broaden future options leads to the maintenance of a sustainable healthcare delivery system.